行情

BAX

BAX

百特国际
NYSE

实时行情|Nasdaq Last Sale

91.07
+1.34
+1.49%
盘后: 91.07 0 0.00% 16:47 01/21 EST
开盘
89.52
昨收
89.73
最高
91.87
最低
89.31
成交量
426.32万
成交额
--
52周最高
90.30
52周最低
68.69
市值
464.96亿
市盈率(TTM)
34.85
分时
5日
1月
3月
1年
5年

分析师评级

16位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BAX 新闻

  • SHAREHOLDER ALERT: REAL BAX FCAU: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  • ACCESSWIRE.5小时前
  • Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Baxter International, Inc.
  • GlobeNewswire.5小时前
  • PerkinElmer (PKI) to Report Q4 Earnings: What's in the Cards?
  • Zacks.10小时前
  • SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS FSCT, MAT, TCNNF, WBAI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
  • GlobeNewswire.18小时前

更多

所属板块

医疗设备、用品及经销
+0.61%
医疗设备和用品
+0.52%

热门股票

名称
价格
涨跌幅

BAX 简况

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
展开

Webull提供Baxter International Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。